Associate professor, senior consultant
Department of Obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Sweden
I am an obstetrician and associate professor within the field of obstetrics but in particular in preeclampsia and maternal organ complications focusing on the maternal brain, affiliated to University of Gothenburg, Sweden, Stellenbosch University, South Africa and Uppsala University, Sweden. My research is translational, from laboratory studies and animal models to clinical studies, epidemiology and intervention trials. I have a large international network of researchers working in the field of preeclampsia that I collaborate with to make use of different methodologies and gather the experts in the field to conduct high quality research. I completed my PhD in October 2017 at Uppsala University which investigated the role of cerebral biomarkers in preeclampsia. I spent a 2-year postdoc fellowship, initiating the Preeclampsia Obstetric Adverse Events (PROVE) –Biobank – together with a local South African researcher A/Prof Cluver at Stellenbosch University in South Africa between 2017-2019. Our research group is expanding and I was recently appointed extraordinary associate professor at Stellenbosch University.
In August 2019, I moved to Gothenburg to establish my own research group at Sahlgrenska Academy, aiming for an associate professor position that I obtained in May 2021. In 2022, I received a large national grant to initiate a treatment trial for early onset preeclampsia, “PI4”. This trial will start in 2023 and is a continuation of our work in South Africa where my research group has shown that treatment with metformin has the potential to prolong pregnancy in early onset disease. Together with an network of Swedish researchers, we have just completed a multicenter cohort study, the “IMPACT” study, where we have included 13 000 women to assess first trimester prediction risk of developing adverse obstetric outcomes including preeclampsia.